SCHEMBL30108022

SCHEMBL30108022

Nc1nc(-c2ccco2)cc(-n2c(-c3ccncc3)nc3cc(OCC4CCNCC4)ccc32)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
KCNH2 Q12809 3/20 0.37
PRKCZ Q05513 2/20 0.37
HTR3A P46098 2/20 0.37
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CCNA1 P78396 1/20 0.35
KDM1A O60341 1/20 0.34
IKBKB O14920 1/20 0.34
CHUK O15111 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SLC6A3 Q01959 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
HRH1 P35367 1/20 0.33
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108002 0.89 ADORA2A (0.37) SLC6A2SLC6A4KCNH2PRKCZHTR3A
SCHEMBL30108043 0.82 ADORA2A (0.41) ADORA2AADORA1MAPK10
SCHEMBL30108077 0.81 SLC6A2 (0.40) SLC6A2SLC6A4KCNH2PRKCZHTR3A
SCHEMBL30107952 0.78 ADORA2A (0.41) ADORA2AADORA1MAPK10
SCHEMBL30108049 0.77 TSHR (0.45) ADORA2AADORA1
SCHEMBL30108054 0.74 SLC2A1 (0.45) ADORA2AADORA1CHEK2
SCHEMBL30108066 0.71 ADORA2A (0.44) ADORA2AADORA1
SCHEMBL30108063 0.71 KDM4E (0.40) ADORA2AADORA1MAPK10
SCHEMBL30108021 0.70 KDM4E (0.36) SLC6A2SLC6A4KCNH2HTR3ACCNA2
SCHEMBL30107960 0.70 SLC6A2 (0.40) SLC6A2SLC6A4KCNH2PRKCZHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed